Beta-nicotinamide mononucleotide (LGD SARLNUVAMID)

N/A

Report date: 2025/06/11 11:18:29
NME

Base Information

Drug NameBeta-nicotinamide mononucleotide (LGD SARLNUVAMID)
Drug Alias NameBeta-nicotinamide mononucleotideBeta-nicotinamide mononucleotide (LGD SARLNUVAMID)
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLgd Sarl
China Registration ClassN/A

Develop Information

Active CompaniesLgd Sarl
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A